Anna Henningham

2.8k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

Anna Henningham is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anna Henningham has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 16 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Anna Henningham's work include Streptococcal Infections and Treatments (21 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Neonatal and Maternal Infections (14 papers). Anna Henningham is often cited by papers focused on Streptococcal Infections and Treatments (21 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Neonatal and Maternal Infections (14 papers). Anna Henningham collaborates with scholars based in Australia, United States and Germany. Anna Henningham's co-authors include Mark J. Walker, Jason N. Cole, Victor Nizet, Martina Sanderson‐Smith, Jason D. McArthur, Christine M. Gillen, Kadaba S. Sriprakash, Timothy C. Barnett, Gursharan S. Chhatwal and Malak Kotb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Anna Henningham

25 papers receiving 1.9k citations

Hit Papers

Disease Manifestations and Pathogenic Mechanisms of Group... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Henningham Australia 19 1.4k 1.1k 391 338 242 26 1.9k
Susanne R. Talay Germany 24 1.5k 1.0× 1.1k 1.0× 589 1.5× 400 1.2× 206 0.9× 38 2.0k
Jason N. Cole Australia 28 2.0k 1.4× 1.5k 1.3× 554 1.4× 590 1.7× 366 1.5× 44 2.8k
Nancy P. Hoe United States 22 1.4k 1.0× 1.2k 1.1× 411 1.1× 463 1.4× 256 1.1× 29 2.1k
Colette Cywes‐Bentley United States 22 608 0.4× 700 0.6× 318 0.8× 607 1.8× 416 1.7× 38 1.8k
P. Patrick Cleary United States 28 1.2k 0.9× 928 0.9× 388 1.0× 499 1.5× 140 0.6× 49 2.0k
Norbert Schnitzler Germany 18 434 0.3× 488 0.4× 338 0.9× 174 0.5× 131 0.5× 42 1.1k
W. Michael McShan United States 21 991 0.7× 632 0.6× 481 1.2× 975 2.9× 85 0.4× 44 2.2k
Thomas Areschoug Sweden 20 719 0.5× 313 0.3× 389 1.0× 494 1.5× 608 2.5× 22 1.7k
А. Н. Суворов Russia 22 520 0.4× 446 0.4× 353 0.9× 961 2.8× 170 0.7× 181 2.1k
E. Magda Barbu United States 15 288 0.2× 828 0.8× 227 0.6× 664 2.0× 164 0.7× 28 1.5k

Countries citing papers authored by Anna Henningham

Since Specialization
Citations

This map shows the geographic impact of Anna Henningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Henningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Henningham more than expected).

Fields of papers citing papers by Anna Henningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Henningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Henningham. The network helps show where Anna Henningham may publish in the future.

Co-authorship network of co-authors of Anna Henningham

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Henningham. A scholar is included among the top collaborators of Anna Henningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Henningham. Anna Henningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kappler, Ulrike, Anna Henningham, Andrew H. Buultjens, et al.. (2024). Tolerance to Haemophilus influenzae infection in human epithelial cells: Insights from a primary cell-based model. PLoS Pathogens. 20(7). e1012282–e1012282. 2 indexed citations
2.
Rivera-Hernández, Tania, Diane G. Carnathan, Johanna Richter, et al.. (2024). Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model. Vaccines. 12(4). 382–382.
3.
Dhouib, Rabeb, Ama‐Tawiah Essilfie, Horst Joachim Schirra, et al.. (2022). Access to highly specialized growth substrates and production of epithelial immunomodulatory metabolites determine survival of Haemophilus influenzae in human airway epithelial cells. PLoS Pathogens. 18(1). e1010209–e1010209. 11 indexed citations
4.
Sly, Peter D., et al.. (2022). Redox Homeostasis in Well-differentiated Primary Human Nasal Epithelial Cells. PubMed. 3(4). 193–206. 4 indexed citations
5.
Yeo, Abrey J., Anna Henningham, Emmanuelle Fantino, et al.. (2019). Increased susceptibility of airway epithelial cells from ataxia-telangiectasia to S. pneumoniae infection due to oxidative damage and impaired innate immunity. Scientific Reports. 9(1). 2627–2627. 18 indexed citations
6.
Lüchtenborg, Christian, Yoann Le Breton, Gérard Lambeau, et al.. (2018). Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects. PLoS Pathogens. 14(10). e1007348–e1007348. 16 indexed citations
7.
Buffalo, Cosmo Z., J. Andrés Valderrama, Anna Henningham, et al.. (2016). Coiled-coil destabilizing residues in the group A Streptococcus M1 protein are required for functional interaction. Proceedings of the National Academy of Sciences. 113(34). 9515–9520. 31 indexed citations
8.
McNeilly, Celia L., Therese Vu, Anna Henningham, et al.. (2016). Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate. PLoS ONE. 11(6). e0156639–e0156639. 7 indexed citations
9.
Henningham, Anna, Simon Döhrmann, Victor Nizet, & Jason N. Cole. (2015). Mechanisms of group AStreptococcusresistance to reactive oxygen species. FEMS Microbiology Reviews. 39(4). 488–508. 62 indexed citations
10.
Secundino, Ismael, Anel Lizcano, Xiaoxia Wang, et al.. (2015). Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. Journal of Molecular Medicine. 94(2). 219–233. 72 indexed citations
11.
Henningham, Anna, M. Yamaguchi, Ramy K. Aziz, et al.. (2014). Mutual Exclusivity of Hyaluronan and Hyaluronidase in Invasive Group A Streptococcus. Journal of Biological Chemistry. 289(46). 32303–32315. 28 indexed citations
12.
Walker, Mark J., Timothy C. Barnett, Jason D. McArthur, et al.. (2014). Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus. Clinical Microbiology Reviews. 27(2). 264–301. 616 indexed citations breakdown →
13.
Sanderson‐Smith, Martina, David M. P. De Oliveira, Julien Guglielmini, et al.. (2014). A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development. The Journal of Infectious Diseases. 210(8). 1325–1338. 221 indexed citations
14.
Moyle, Peter M., Jon Hartas, Anna Henningham, et al.. (2013). An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 935–944. 29 indexed citations
15.
Henningham, Anna, Emiliano Chiarot, Christine M. Gillen, et al.. (2012). Conserved anchorless surface proteins as group A streptococcal vaccine candidates. Journal of Molecular Medicine. 90(10). 1197–1207. 49 indexed citations
16.
Bauer, Michelle J., Melina Georgousakis, Therese Vu, et al.. (2012). Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein. Vaccine. 30(12). 2197–2205. 26 indexed citations
17.
Henningham, Anna, Christine M. Gillen, & Mark J. Walker. (2012). Group A Streptococcal Vaccine Candidates: Potential for the Development of a Human Vaccine. Current topics in microbiology and immunology. 368. 207–242. 27 indexed citations
18.
Cole, Jason N., Anna Henningham, Christine M. Gillen, Vidiya Ramachandran, & Mark J. Walker. (2008). Human pathogenic streptococcal proteomics and vaccine development. PROTEOMICS - CLINICAL APPLICATIONS. 2(3). 387–410. 36 indexed citations
19.
Walker, Mark J., Andrew Hollands, Martina Sanderson‐Smith, et al.. (2007). DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nature Medicine. 13(8). 981–985. 338 indexed citations
20.
Cole, Jason N., J. Andrew Aquilina, Peter G. Hains, et al.. (2007). Role of group A Streptococcus HtrA in the maturation of SpeB protease. PROTEOMICS. 7(24). 4488–4498. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026